Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Smith & Nephew PLC Director's Dealing 2024

Dec 9, 2024

4588_dirs_2024-12-09_004f007d-f270-42e8-8aa2-14627d9c2d76.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3817P

Smith & Nephew Plc

09 December 2024

SMITH & NEPHEW PLC

9 December 2024

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

On 6 December 2024 the following ordinary shares of US$0.20 (the "Shares") in Smith & Nephew plc (the "Company") were purchased in line with Smith & Nephew plc's Remuneration Policy to pay part of its Non-Executive Directors' fees in Shares.  These Shares were purchased net of tax and expenses.

Reason for the notification
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
LEI 213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code ISIN: GB0009223206
Nature of the transaction Share purchase in lieu of part of annual fees.
Date of Transaction 2024 - 12 - 06
Place of Transaction London Stock Exchange (XLON)
Name Director / PDMR Price Volume Aggregated information
Jo Hallas Non-Executive Director £9.80279 535

ordinary shares
N/A Single Transaction

Helen Barraclough

General Counsel & Company Secretary

Smith & Nephew plc

Tel:  +44 (0)1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVSFELAIIS